A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

Maria Juárez ¹ AuthorId : 11346805
Author

Nieves Diaz ¹ AuthorId : 11505935
Author

Geoffrey I Johnston ¹ AuthorId : 11505936
Author

Saba Nayar ² AuthorId : 1577591
Author

Andrew Payne ¹ AuthorId : 11505937
Author

Eric Helmer ¹ AuthorId : 11505938
Author

Dionne Cain ¹ AuthorId : 11505939
Author

Paulette Williams ³ AuthorId : 11505940
Author

Wan Fai Ng ⁴ AuthorId : 1559935
Author

Benjamin Fisher ² AuthorId : 1559930
Author

Jacques-Eric Gottenberg ⁵ AuthorId : 117611
Author

Giuliana Guggino ⁶ AuthorId : 11505941
Author

Xavier Mariette ⁷ AuthorId : 417928
Mail :
Author

Marika Kvarnström ⁸ AuthorId : 1580534
Author

Valérie Devauchelle-Pensec ^{9, 10} AuthorId : 1303661
Mail :
Author Employer institution : Centre Hospitalier Régional Universitaire de Brest

Jose Rosas ¹¹ AuthorId : 11505942
Author

Juan Sanchez-Burson ¹² AuthorId : 11505943
Author

Roberto Giacomelli ¹³ AuthorId : 1442401
Author

Francesca Barone ² AuthorId : 1443191
Mail :
Author IdHAL : francesca-barone

Simon J Bowman ¹⁴ AuthorId : 1275542
Author